RRAD antibody (Middle Region)
-
- Target See all RRAD Antibodies
- RRAD (Ras-Related Associated with Diabetes (RRAD))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This RRAD antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- RRAD antibody was raised against the middle region of RRAD
- Purification
- Affinity purified
- Immunogen
- RRAD antibody was raised using the middle region of RRAD corresponding to a region with amino acids LARIFGGVEDGPEAEAAGHTYDRSIVVDGEEASLMVYDIWEQDGGRWLPG
- Top Product
- Discover our top product RRAD Primary Antibody
-
-
- Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
RRAD Blocking Peptide, catalog no. 33R-4793, is also available for use as a blocking control in assays to test for specificity of this RRAD antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RRAD antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- RRAD (Ras-Related Associated with Diabetes (RRAD))
- Alternative Name
- RRAD (RRAD Products)
- Synonyms
- ZGC:63471 antibody, RRAD antibody, RAD antibody, RAD1 antibody, REM3 antibody, Rad antibody, RRAD, Ras related glycolysis inhibitor and calcium channel regulator antibody, Ras-related associated with diabetes antibody, RRAD antibody, Rrad antibody
- Background
- RRAD may play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca2+ currents.
- Molecular Weight
- 33 kDa (MW of target protein)
-